So the first one, labelled "(a)" there is, of course, the COVID-19 vaccine that we're discussing. But there are five further ones: item (b) and item (e) are both oral contraceptive pills. And I think this is a really interesting illustration, because we experienced both issues with manufacturer problems with supply, and also supply chain disruption in the last year. That meant that there was a realistic possibility of there being no oral contraceptive pill available. Now, if we were only to have an emergency medicine authorisation process, I'm not sure if that would meet the definition of an emergency. But there is certainly a clear public health need for that. Both of those medicines were approved in other jurisdictions, and on that basis, and the basis of other data that was able to be provided to Medsafe, they were approved. Item (d) and item (f) are both influenza A vaccines, suitable for use in a pandemic, and they have both been subject to conditional approval since 2012—obviously with the two-yearly renewal of that status, as is required by all conditional approvals.